摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,6-dichloro-2-(5-methoxyhept-1-yl)bicyclo[3.2.0]heptan-7-one {7,7-dichloro-4-(5-methoxyheptyl)bicyclo [3.2.0]heptan-6-one}

中文名称
——
中文别名
——
英文名称
6,6-dichloro-2-(5-methoxyhept-1-yl)bicyclo[3.2.0]heptan-7-one {7,7-dichloro-4-(5-methoxyheptyl)bicyclo [3.2.0]heptan-6-one}
英文别名
7,7-dichloro-4-(5-methoxyheptyl)bicyclo [3.2.0]heptan-6-one;6,6-dichloro-2-(5-methoxyhept-1-yl)bicyclo[3.2.0]heptan-7-one {7,7-dichloro-4-(5-methoxyheptyl)bicyclo[3.2.0]heptan-6-one};7,7-dichloro-4-(5-methoxyheptyl)bicyclo[3.2.0]heptan-6-one
6,6-dichloro-2-(5-methoxyhept-1-yl)bicyclo[3.2.0]heptan-7-one {7,7-dichloro-4-(5-methoxyheptyl)bicyclo [3.2.0]heptan-6-one}化学式
CAS
——
化学式
C15H24Cl2O2
mdl
——
分子量
307.26
InChiKey
JLRSEZNMECHORC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • Oxygenated alkyl substituted bicyclo alkanes
    申请人:CBD Corporation
    公开号:US04689345A1
    公开(公告)日:1987-08-25
    Anti-androgenic composition compound of the formula ##STR1## wherein Q is CO, CH(OR), CR(OH), or CR (OC)-lower alkyl); R is H, or C.sup.1-2 -alkyl; X is hydroxyalkyl, methoxy-C.sup.2-11 -alkyl, ethoxy-C.sup.2-11 -alkyl or oxo-C.sup.2-11 -alkyl, formyl-C.sup.2-11 -alkyl, carboxy-C.sup.2-11 -alkyl or (C.sub.1-2 -alkyl) oxycarbonyl-C.sup.2-11 -alkyl; c is 1 or 2; p or w are 0, 1 or 2 and the sum of p and w is 1 to 4; and a pharmaceutically acceptable salt thereof.
    公式为##STR1##的抗雄激素化合物组合物,其中Q为CO、CH(OR)、CR(OH)、或CR(OC)-低碳基); R为H或C.sup.1-2-烷基; X为羟基烷基、甲氧基-C.sup.2-11-烷基、乙氧基-C.sup.2-11-烷基或氧代-C.sup.2-11-烷基、甲酰-C.sup.2-11-烷基、羧基-C.sup.2-11-烷基或(C.sub.1-2-烷基)氧羰基-C.sup.2-11-烷基; c为1或2; p或w为0、1或2,p和w的总和为1至4;以及其药学上可接受的盐。
  • Anti-tumor halo bicyclo alkanones
    申请人:CBD Corporation
    公开号:US04689349A1
    公开(公告)日:1987-08-25
    Potent tumor inhibitors are prepared which are compounds of the formula: ##STR1## wherein Q is CO, CH(OH) or C(OH)CH.sub.3, M.sub.1 is halogen, M.sub.2 is halogen or hydrogen, c is one or two p is 0 or 1, and one of X and X' is H and the other is hydroxy-C.sup.2-9 alkyl, methoxy-C.sup.2-9 -alkyl, ethoxy-C.sup.2-9 -alkyl, oxo-C.sup.2-9 -alkyl, formyl-C.sup.2-9 -alkyl, carboxy-C.sup.2-9 -alkyl or (C.sub.1-2 -alkyl)oxycarbonyl-C.sup.2-9 -alkyl.
    制备了一些具有强效抑制肿瘤活性的化合物,其化学式为:##STR1## 其中,Q为CO、CH(OH)或C(OH)CH.sub.3,M.sub.1为卤素,M.sub.2为卤素或氢,c为1或2,p为0或1,X和X'中的一个为H,另一个为羟基-C.sup.2-9烷基、甲氧基-C.sup.2-9-烷基、乙氧基-C.sup.2-9-烷基、氧代-C.sup.2-9-烷基、甲酰-C.sup.2-9-烷基、羧基-C.sup.2-9-烷基或(C.sub.1-2-烷基)氧羰基-C.sup.2-9-烷基。
  • Spiro[bicyclo[3.2.0]heptane-6,2'-oxirane] derivatives
    申请人:CBD Corporation
    公开号:US04731458A1
    公开(公告)日:1988-03-15
    Compounds of the formula ##STR1## are described wherein X is a C.sup.2-11 -alkyl group, optionally substituted by a protected hydroxy, protected oxo or protected carboxy group.
    描述了化学式为##STR1##的化合物,其中X是C.sup.2-11烷基,可选择性地被保护羟基、保护羰基或保护羧基取代。
  • Radiation-curable adhesive tape
    申请人:THE FURUKAWA ELECTRIC CO., LTD.
    公开号:EP0298448A2
    公开(公告)日:1989-01-11
    There is provided a radiation-curable adhesive tape comprising a radiation-curable adhesive layer which is formed on a radiation transmitting-substrate. The radiation-curable adhesive layer is composed of an acrylic adhesive and radiation-curable compound having carbon-carbon double bonds. The radiation-curable tape can be used preferably in processing steps for the production of semiconductor wafer, ceramics and glass employing a direct picking-up system.
    本发明提供了一种辐射固化胶带,它由辐射固化胶粘层组成,该胶粘层形成于辐射透射基底上。辐射固化粘合剂层由丙烯酸粘合剂和具有碳碳双键的辐射固化化合物组成。该辐射固化胶带可优先用于采用直接拾取系统生产半导体晶片、陶瓷和玻璃的加工步骤中。
  • Method of synthesis of methoxyheptyl bicyclooctanone
    申请人:Grey Pacific Labs, LLC
    公开号:US10150724B2
    公开(公告)日:2018-12-11
    Described is a method of synthesizing 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0] octan-3-one by reacting 3-(5-ethoxyhept-1-yl) cyclopentene with dichloroketene. The resulting reaction products are reacted with acetic acid and zinc to produce 4-(5-ethoxyhept-1-yl)bicyclo[3.2.0]heptan-6-one and 4-(5-ethoxyhept-1-yl)bicyclo [3.2.0]heptan-7-one, which are reacted with trimethylsulfonium iodide to produce 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2′-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[3.2.0]heptane-6,2′-oxirane]. Lithium iodide is reacted with 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2′-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[ 3.2.0]heptane-6,2′-oxirane] to produce 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one. A method of synthesizing 6-(5-methoxyhept-1-yl)bicyclo[3.3.0]octan-3-one is also described.
    描述了一种通过 3-(5-乙氧基庚-1-基)环戊烯二氯甲烷反应合成 6-(5-乙氧基庚-1-基)双环[3.3.0]辛烷-3-酮的方法。反应生成物与乙酸反应生成 4-(5-乙氧基庚-1-基)双环[3.2.0]庚-6-酮和 4-(5-乙氧基庚-1-基)双环[3.2.0]庚烷-7-酮,与三甲基碘化锍反应生成 2-(5-乙氧基庚-1-基)螺[双环[3.2.0]庚烷-6,2′-环氧乙烷]和 4-(5-乙氧基庚-1-基)螺[双环[3.2.0]庚烷-6,2′-环氧乙烷]。与 2-(5-乙氧基庚-1-基)螺[双环[3.2.0]庚烷-6,2′-环氧乙烷]和 4-(5-乙氧基庚-1-基)螺[双环[3.2.0]庚烷-6,2′-环氧乙烷]反应,生成 6-(5-乙氧基庚-1-基)双环[3.3.0]辛烷-3-酮。还描述了合成 6-(5-甲氧基庚-1-基)双环[3.3.0]辛-3-酮的方法。
查看更多